Due to the latest concern about the vaccinated young students for the anti-dengue vaccine known as Dengvaxia, a Party List representative from the Philippines is asking the Supreme Court (SC) to give an obligation to the responsible government agencies in monitoring the involved students nationwide.
From the latest shared online report through news.mb.com.ph, Representative Emmi de Jesus alongside the Association for the Rights of Children in Southeast Asia (ARCSEA) filed a petition for continuing madamus to the Supreme Court (SC).
They wanted the SC to oblige the Department of Education (DepEd), Department of Health (DOH) and Department of Interior and Local Government (DILG) to monitor nearly 800,000 young students within the Philippines whom they vaccinated with the anti-dengue medicine called Dengvaxia vaccine.
De Jesus is the current Gabriela Party-List Representative.
The petitioners believe that the SC must have a registry of those involved kids so that the country is prepared enough if they need urgent medicinal services without any delay.
Likewise, it is important for the government to provide free medical services to the students that include medical attention, consultations, checkups and blood testing. It is necessary for the authorized government agencies to facilitate such needs to assure the wellness of the children.
“These free medical services shall continue until it would have been determined and declared by competent medical and/or scientific experts that the threat/s brought about by the Dengvaxia vaccine have been minimized or eliminated,” said the petitioners as quoted by the online news.
“There are reports that the DOH will provide monetary compensation to those who were inoculated with Dengvaxia. However, petitioners maintain their position that monetary rewards are not enough to compensate for the injury brought to them by this medical scandal,” added by the filed petition.
“What is important for them is that they be ensured immediate and free medical attention and services in their medical needs that are attributable to the Dengvaxia vaccine,” the petitioners added.
Due the Holiday breaks, the SC is not available to take action but will be back on January 8, 2018 for the continuing of their sessions. However, they may still provide their opinions or actions even if they are not in session.
The issue about this particular anti-dengue vaccine came out few weeks ago and triggered concern to many Filipinos.
Credit image: Inquirer News